Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

IrelandBack to Ireland

Clinical trials in Limerick – page 2

38 clinical trials in Limerick, Ireland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Limerick at a glance
38
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

38 trials in Limerick

Open in trial search

Cystic fibrosis

Recruiting

Study on Long-Term Safety and Effectiveness of Vanzacaftor, Tezacaftor, and Deutivacaftor for Cystic Fibrosis in Patients Aged 1 Year and Older

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:0–17 years
  • Substances:Deutivacaftor
  • Sponsor:Vertex Pharmaceuticals Inc.

Triple negative breast cancer

Recruiting

Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Gilead Sciences Inc.

Diffuse large B-cell lymphoma

Not yet recruiting

Epcoritamab plus rituximab versus rituximab alone in elderly, frail or unfit patients with newly diagnosed diffuse large B‑cell lymphoma

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:65+ years
  • Substances:Epcoritamab
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Postoperative wound infection

Not yet recruiting

Study on Erythromycin and Neomycin for Preventing Infections After Colorectal Surgery in Patients Undergoing Elective Procedures

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Erythromycin
  • Sponsor:University Hospital Limerick

Non-small cell lung cancer metastatic

Not recruiting

Study Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Acasunlimab
  • Sponsor:Genmab A/S

Obesity+1

Not recruiting

Study on Semaglutide for Patients with Obesity and Resistant Hypertension to Improve Blood Pressure Control

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Trinity College Dublin

Hormone receptor positive breast cancer

Not recruiting

Study on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Palbociclib
  • Sponsor:ABCSG GmbH

Embolism venous

Not recruiting

Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Acute myeloid leukaemia+1

Not recruiting

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Gilteritinib
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Breast cancer+7

Not recruiting

Study of sacituzumab govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:GBG Forschungs GmbH

Breast cancer

Not recruiting

Study on the Effects of Chemotherapy and Endocrine Therapy in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer Using Tamoxifen and Anastrozole

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Cancer Trials Ireland

Plasma cell myeloma

Not recruiting

Study on the Effectiveness and Safety of Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Cancer Trials Ireland

Other cities in Ireland

The busiest research cities in the country

All 16 cities in Ireland

Clinical research in Limerick

What the registry says about research in the country

01 Hematologic Oncology

Innovative clinical trials focusing on blood cancers and related disorders, including studies on lymphoma, leukemia, and multiple myeloma. Research explores novel therapeutic combinations and treatment strategies.

  • Diffuse Large B-Cell Lymphoma
  • Chronic Lymphocytic Leukemia
  • Multiple Myeloma

Studies evaluate targeted therapies and immunotherapy approaches for improved patient outcomes.

02 Solid Tumors

Comprehensive research into various solid cancers, with particular emphasis on breast cancer and lung cancer. Studies evaluate novel therapeutic approaches and treatment combinations.

  • Non-Small Cell Lung Cancer
  • HER2-Positive Breast Cancer
  • Ovarian Cancer

Trials focus on targeted therapies, immunotherapies, and precision medicine approaches.

03 Cardiovascular and Metabolic Research

Studies addressing cardiovascular conditions and metabolic disorders, with a focus on innovative treatment approaches for complex cases.

  • Resistant Hypertension
  • Obesity Management
  • Cardiovascular Risk Factors

Research evaluates new therapeutic options for patients with challenging cardiovascular conditions.

Back to IrelandAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.